The following represents disclosure information provided by authors of this abstract. The ASCO-NCI-EORTC Annual Meeting on Molecular Markers in Cancer Planning Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
NGS-based targeted RNA sequencing for expression analysis of patients with triple-negative breast cancer using a modulized, 96-gene biomarker panel.
Byung-In Lee
Employment or Leadership Position - AltheaDx
Kahuku Oades
Employment or Leadership Position - AltheaDx
Lien Vo
Employment or Leadership Position - AltheaDx
Jerry Lee
Employment or Leadership Position - AltheaDx
Mark Landers
Employment or Leadership Position - AltheaDx
Yipeng Wang
Employment or Leadership Position - AltheaDx
Joseph Monforte
Employment or Leadership Position - AltheaDx